Competitive enzyme immunoassay for apolipoprotein A-II

Area of Science:

• Biochemistry
• Immunology
• Clinical Chemistry

Background:

• Apolipoprotein A-II (ApoA-II) is a significant component of high-density lipoprotein (HDL).
• Accurate quantification of ApoA-II is crucial for understanding lipid metabolism and cardiovascular disease risk.
• Existing methods for ApoA-II measurement may have limitations in routine clinical application.

Purpose of the Study:

• To develop and validate a competitive enzyme immunoassay for the accurate quantification of apolipoprotein A-II.
• To assess the assay's performance characteristics, including parallelism, specificity, and precision.
• To determine the suitability of the developed assay for routine clinical laboratory use.

Main Methods:

• Development of a competitive enzyme immunoassay using microtitre plates coated with anti-ApoA-II antibodies.
• Use of purified apolipoprotein A-II labeled with horseradish peroxidase as the competing ligand.
• Optimization of antibody and enzyme conjugate concentrations and evaluation of displacement curves.

Main Results:

• The developed assay demonstrated good parallelism between serum and purified apolipoprotein A-II.
• Delipidation of serum did not impact apolipoprotein A-II content measurements.
• Minimal cross-reactivity was observed with apolipoprotein A-I.
• Intra- and inter-assay coefficients of variation were 9.0% and 11.8% respectively at the medium concentration range.

Conclusions:

• A robust competitive enzyme immunoassay for apolipoprotein A-II has been successfully developed.
• The assay exhibits favorable characteristics for clinical application, including good parallelism, specificity, and precision.
• This method is well-suited for routine clinical laboratory analysis of apolipoprotein A-II levels.